BE839306A - Vaccin d'immunisation active contre l'hepatite virale et procede de preparation - Google Patents

Vaccin d'immunisation active contre l'hepatite virale et procede de preparation

Info

Publication number
BE839306A
BE839306A BE164943A BE164943A BE839306A BE 839306 A BE839306 A BE 839306A BE 164943 A BE164943 A BE 164943A BE 164943 A BE164943 A BE 164943A BE 839306 A BE839306 A BE 839306A
Authority
BE
Belgium
Prior art keywords
preparation
viral hepatitis
against viral
immunization against
active immunization
Prior art date
Application number
BE164943A
Other languages
English (en)
Inventor
A M Prince
J Vnek
A R Neurath
Ch Trepo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE839306A publication Critical patent/BE839306A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
BE164943A 1975-03-14 1976-03-08 Vaccin d'immunisation active contre l'hepatite virale et procede de preparation BE839306A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7508046A FR2303562A1 (fr) 1975-03-14 1975-03-14 Nouvelle preparation d'antigene utilisable comme vaccin

Publications (1)

Publication Number Publication Date
BE839306A true BE839306A (fr) 1976-07-01

Family

ID=9152597

Family Applications (1)

Application Number Title Priority Date Filing Date
BE164943A BE839306A (fr) 1975-03-14 1976-03-08 Vaccin d'immunisation active contre l'hepatite virale et procede de preparation

Country Status (4)

Country Link
US (1) US4118479A (fr)
BE (1) BE839306A (fr)
FR (1) FR2303562A1 (fr)
ZA (1) ZA761346B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2750045A1 (de) * 1977-11-09 1979-05-10 Behringwerke Ag Verfahren zur entfernung von detergentien aus virusantigensuspensionen
US4181713A (en) * 1978-10-30 1980-01-01 Merck & Co., Inc. Isolation of HBs Ag
JPS5610119A (en) * 1979-07-05 1981-02-02 Alpha Therapeutic Corp Manufacture of b type hepatitis infection preventive vaccine
US4412985A (en) * 1980-10-06 1983-11-01 Edward Shanbrom Depyrogenation process
US4617260A (en) * 1981-02-27 1986-10-14 Merck & Co., Inc. RIA assay for HBcAg
PL133476B1 (en) * 1981-06-10 1985-06-29 Akad Medyczna Method of obtaining pure antigen hba from human serum
AU8746582A (en) * 1981-09-02 1983-03-10 Biogen N.V. Hepatitis b virus e type antigen
GB8321789D0 (en) * 1983-08-12 1983-09-14 Biogen Nv Vaccines and compositions against hepatitis
US5324513A (en) * 1984-03-07 1994-06-28 Institut Pasteur Composition useful for the fabrication of vaccines
US4649192A (en) * 1985-05-30 1987-03-10 Smith Kline-Rit Method for the isolation and purification of hepatitis B surface antigen using polysorbate
US6025141A (en) * 1993-12-10 2000-02-15 The Canadian Red Cross Society Immunofluorescence assay for the detection of antibodies using recombinant antigens in insoluble form

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1356413A (en) * 1971-09-09 1974-06-12 Pfizer Ltd Method of obtaining purified australia antigen from blood serum
US3951937A (en) * 1973-12-20 1976-04-20 The Community Blood Council Of Greater New York, Inc. Large scale purification of hepatitis type B antigen using polyethylene glycol
US3976767A (en) * 1975-04-14 1976-08-24 The New York Blood Center Purification of hepatitis B surface antigen by chromatography on agarose containing aminoalkyl residues

Also Published As

Publication number Publication date
US4118479A (en) 1978-10-03
FR2303562B1 (fr) 1978-08-04
ZA761346B (en) 1977-02-23
FR2303562A1 (fr) 1976-10-08

Similar Documents

Publication Publication Date Title
NL930133I1 (nl) Vaccin tegen hepatitis B virus werkwijze en getransformeerde eukaryotische cellen en de bereiding van dat vaccin
FR2344629A1 (fr) Procede pour la purification et l'isolement de virus de l'hepatite utilisable pour la preparation d'un vaccin
BE786240Q (fr) Vaccin contre l'hepatite virale et sa preparation
FR2353641A1 (fr) Vaccin anti-tumoral et son procede de preparation
BE858992A (fr) Procede de preparation de vaccins
BE841811A (fr) Vaccin contre l'hepatite b
BE863676A (fr) Vaccin syncytial du virus respiratoires
BE839306A (fr) Vaccin d'immunisation active contre l'hepatite virale et procede de preparation
FR2346022A1 (fr) Vaccin contre la rhinotracheite virale des felides et son procede de preparation
ZA784324B (en) High molecular weight meningococcal group c vaccine and method for preparation thereof
BE880616A (fr) Preparation de vaccin vivant attenue du virus des oeillons
FR2326205A1 (fr) Methode pour detecter des antigenes et anticorps de l'hepatite et vaccin contre l'hepatite
FR2293218A1 (fr) Vaccin contre les oreillons et son procede de preparation
NZ181498A (en) A live rabies virus and a vaccine there of
FR2331354A2 (fr) Vaccin d'immunisation active contre l'hepatite virale et procede de preparation
BE850696A (fr) Vaccin contre la panleucopenie des felides et son procede de preparation
PT70556A (en) Vaccines against diseases caused by reo-virus and process for the preparation of those vaccines
BE871586A (fr) Vaccin contre haemophilus influenzae et procede pour sa preparation
BE882684A (fr) Procede de preparation d'un vaccin antirabique et vaccin obtenu suivant ce procede
ZA796944B (en) Vaccines against diseases,caused by reovirus,and process for the preparation of those vaccines
FR2313942A1 (fr) Compositions antigeniques, leur procede de preparation et leur application comme vaccins
GB1552611A (en) Vaccine for immunization of swine against bordetella brochiseptica infection and method of use
IL47784A (en) Method for cultivating foot and mouth disease(fmd) virus
FR2602681B1 (fr) Procede de preparation d'un vaccin recombinant contre l'hepatite b
DK477180A (da) Vaccine og fremgangsmaade til fremstilling heraf

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: THE COMMUNITY BLOOD COUNCIL OF GREATER NEW-YORK I

Effective date: 19870331